Inventor · disambiguated record
Cliona M. Rooney
Also filed as: ROONEY CLIONA · ROONEY CLIONA M
24 granted patents·27 pending applications·618 citations·filing 1996–2024
96Inventor score
Top patents by PatentIndex Score
51 records- 0198US10533156B2Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2016·Granted Jan 14, 2020·30 cites·20 claims
- 0298US8956860B2Methods of cell culture for adoptive cell therapyVERA JUAN F·Filed 2012·Granted Feb 17, 2015·197 cites·21 claims
- 0398US8809050B2Methods of cell culture for adoptive cell therapyVERA JUAN F·Filed 2010·Granted Aug 19, 2014·173 cites·14 claims
- 0497US11999969B2Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2023·Granted Jun 4, 2024·2 cites·20 claims
- 0596US9567565B2Methods of cell culture for adoptive cell therapyVERA JUAN F·Filed 2014·Granted Feb 14, 2017·33 cites·23 claims
- 0694US11268066B2Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2019·Granted Mar 8, 2022·3 cites·24 claims
- 0793US11155784B2Process of expanding T cellsBAYLOR COLLEGE MEDICINE·Filed 2018·Granted Oct 26, 2021·8 cites·21 claims
- 0893US11118164B2Pepmixes to generate multiviral CTLs with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2018·Granted Sep 14, 2021·7 cites·14 claims
- 0992US12454667B2Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2024·Granted Oct 28, 2025·0 cites·12 claims
- 1091US10385316B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2016·Granted Aug 20, 2019·8 cites·15 claims
- 1191US9642906B2Generation of HPV-specific T-cellsBAYLOR COLLEGE MEDICINE·Filed 2016·Granted May 9, 2017·14 cites·15 claims
- 1289US9963677B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesLEEN ANN M·Filed 2010·Granted May 8, 2018·14 cites·28 claims
- 1386US10351824B2Process of expanding T cellsROONEY CLIONA M·Filed 2012·Granted Jul 16, 2019·12 cites·44 claims
- 1486US2024408200A1Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2024·Application pending·0 cites
- 1585US10772914B1EBV-specific immune cellsBAYLOR COLLEGE MEDICINE·Filed 2019·Granted Sep 15, 2020·3 cites·13 claims
- 1685US2023357721A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2023·Application pending·0 cites
- 1784US11821002B2Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2022·Granted Nov 21, 2023·0 cites·18 claims
- 1883US5962318ACytotoxic T lymphocyte-mediated immunotherapyST JUDE CHILDRENS RES HOSPITAL·Filed 1996·Granted Oct 5, 1999·112 cites·33 claims
- 1983US2024002797A1Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2023·Application pending·0 cites
- 2083US2023114971A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 2183US2023383250A1Methods of cell culture for adoptive cell therapyWILSON WOLF MFG·Filed 2023·Application pending·0 cites
- 2282US12435309B2Generation of CTL lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2022·Granted Oct 7, 2025·0 cites·8 claims
- 2380US11981923B2Pepmixes to generate multiviral CTLS with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2022·Granted May 14, 2024·0 cites·11 claims
- 2477US12227764B2Pepmixes to generate multiviral CTLs with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2021·Granted Feb 18, 2025·0 cites·21 claims
- 2576US2024301028A1Chimeric hla accessory receptorBAYLOR COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 2674US10584158B2Immunosuppressive TGF-β signal converterBAYLOR COLLEGE MEDICINE·Filed 2014·Granted Mar 10, 2020·2 cites·3 claims
- 2774US2022152111A1Process for t cell expansionALLOVIR INC·Filed 2022·Application pending·0 cites
- 2869US2025002558A1Constitutively active cytokine receptors for cell therapyBAYLOR COLLEGE MEDICINE·Filed 2024·Application pending·0 cites
- 2968US2023172986A1Treatment and prevention of alloreactivity using virus-specific immune cells expressing chimeric antigen receptorsBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 3068US2023220097A1Treatment and prevention of cancer using virus-specific immune cells expressing chimeric antigen receptorsBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 3167US2023167187A1Virus-specific immune cells expressing chimeric antigen receptorsBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 3267US2019264176A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 3366US2019144826A1Generation of ctl lines with specificity against multiple tumor antigens or multiple virusesBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 3465US11963979B2Process for T cell expansionALLOVIR INC·Filed 2018·Granted Apr 23, 2024·0 cites·28 claims
- 3565US11590218B2Generation of HPV-specific T-cellsBAYLOR COLLEGE MEDICINE·Filed 2017·Granted Feb 28, 2023·0 cites·17 claims
- 3665US2021077612A1Generation of hpv-specific t-cellsBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 3764US2025325668A1Targeting common somatic mutations in breast cancer with neo-antigen specific adoptive t cell therapyBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 3864US2016208216A1Methods of cell culture for adoptive cell therapyVERA JUAN F·Filed 2016·Application pending·0 cites
- 3963US2022251509A1Platform for activation and expansion of virus-specific t-cellsBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 4063US2021238255A1Chimeric hla accessory receptorBAYLOR COLLEGE MEDICINE·Filed 2019·Application pending·0 cites
- 4162US2015010519A1Pepmixes to generate multiviral ctls with broad specificityBAYLOR COLLEGE MEDICINE·Filed 2013·Application pending·0 cites
- 4260US2024376429A1Virus-specific immune cells expressing chimeric antigen receptorsBAYLOR COLLEGE MEDICINE·Filed 2022·Application pending·0 cites
- 4358US2020140520A1Immunosuppressive tgf-b signal converterBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 4455US12102652B2Constitutively active cytokine receptors for cell therapyBAYLOR COLLEGE MEDICINE·Filed 2017·Granted Oct 1, 2024·0 cites·21 claims
- 4555US10500265B2Generation of HPV-specific T-cellsBAYLOR COLLEGE MEDICINE·Filed 2018·Granted Dec 10, 2019·0 cites·22 claims
- 4655US2023210901A1Overcoming the tumor microenvironment for cell therapy by targeting myeloid derived suppressor cells through a trail-r2 specific receptorBAYLOR COLLEGE MEDICINE·Filed 2021·Application pending·0 cites
- 4752US2022401478A1Ebv-specific immune cellsBAYLOR COLLEGE MEDICINE·Filed 2020·Application pending·0 cites
- 4844US2014086888A1Ebv-specific cytotoxic t-lymphocytes for the treatment of locoregional nasopharyngeal carcinoma (npc)HESLOP HELEN E·Filed 2011·Application pending·0 cites
- 4944US2003148982A1Bi-spcific chimeric T cellsFiled 2002·Application pending·0 cites
- 5043US2019194619A1Platform for activation and expansion of virus-specific t-cellsBAYLOR COLLEGE MEDICINE·Filed 2017·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Cliona M. Rooney files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →